Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT05239624
Conditions
Urothelial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Enfortumab vedotin
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-25. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-02-26.